![](/img/cover-not-exists.png)
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial
Maher, Toby M, van der Aar, Ellen M, Van de Steen, Olivier, Allamassey, Lisa, Desrivot, Julie, Dupont, Sonia, Fagard, Liesbeth, Ford, Paul, Fieuw, Ann, Wuyts, WimLanguage:
english
Journal:
The Lancet Respiratory Medicine
DOI:
10.1016/S2213-2600(18)30181-4
Date:
May, 2018
File:
PDF, 383 KB
english, 2018